QQQ   351.70 (+1.07%)
AAPL   179.61 (+1.33%)
MSFT   332.23 (+1.17%)
META   271.64 (+2.61%)
GOOGL   123.30 (+0.35%)
AMZN   122.52 (+1.61%)
TSLA   207.50 (+1.75%)
NVDA   397.36 (+5.03%)
NIO   7.52 (-0.13%)
BABA   83.01 (+4.35%)
AMD   119.96 (+1.48%)
T   15.82 (+0.57%)
F   12.09 (+0.75%)
MU   69.15 (+1.39%)
CGC   0.83 (-0.35%)
GE   104.40 (+2.83%)
DIS   88.54 (+0.66%)
AMC   4.51 (+0.22%)
PFE   37.96 (-0.16%)
PYPL   62.98 (+1.60%)
NFLX   402.45 (+1.83%)
QQQ   351.70 (+1.07%)
AAPL   179.61 (+1.33%)
MSFT   332.23 (+1.17%)
META   271.64 (+2.61%)
GOOGL   123.30 (+0.35%)
AMZN   122.52 (+1.61%)
TSLA   207.50 (+1.75%)
NVDA   397.36 (+5.03%)
NIO   7.52 (-0.13%)
BABA   83.01 (+4.35%)
AMD   119.96 (+1.48%)
T   15.82 (+0.57%)
F   12.09 (+0.75%)
MU   69.15 (+1.39%)
CGC   0.83 (-0.35%)
GE   104.40 (+2.83%)
DIS   88.54 (+0.66%)
AMC   4.51 (+0.22%)
PFE   37.96 (-0.16%)
PYPL   62.98 (+1.60%)
NFLX   402.45 (+1.83%)
QQQ   351.70 (+1.07%)
AAPL   179.61 (+1.33%)
MSFT   332.23 (+1.17%)
META   271.64 (+2.61%)
GOOGL   123.30 (+0.35%)
AMZN   122.52 (+1.61%)
TSLA   207.50 (+1.75%)
NVDA   397.36 (+5.03%)
NIO   7.52 (-0.13%)
BABA   83.01 (+4.35%)
AMD   119.96 (+1.48%)
T   15.82 (+0.57%)
F   12.09 (+0.75%)
MU   69.15 (+1.39%)
CGC   0.83 (-0.35%)
GE   104.40 (+2.83%)
DIS   88.54 (+0.66%)
AMC   4.51 (+0.22%)
PFE   37.96 (-0.16%)
PYPL   62.98 (+1.60%)
NFLX   402.45 (+1.83%)
QQQ   351.70 (+1.07%)
AAPL   179.61 (+1.33%)
MSFT   332.23 (+1.17%)
META   271.64 (+2.61%)
GOOGL   123.30 (+0.35%)
AMZN   122.52 (+1.61%)
TSLA   207.50 (+1.75%)
NVDA   397.36 (+5.03%)
NIO   7.52 (-0.13%)
BABA   83.01 (+4.35%)
AMD   119.96 (+1.48%)
T   15.82 (+0.57%)
F   12.09 (+0.75%)
MU   69.15 (+1.39%)
CGC   0.83 (-0.35%)
GE   104.40 (+2.83%)
DIS   88.54 (+0.66%)
AMC   4.51 (+0.22%)
PFE   37.96 (-0.16%)
PYPL   62.98 (+1.60%)
NFLX   402.45 (+1.83%)

Medtronic (MDT) Stock Forecast, Price & News

$82.73
-0.03 (-0.04%)
(As of 03:52 PM ET)
Compare
Today's Range
$82.44
$83.25
50-Day Range
$77.57
$91.38
52-Week Range
$75.76
$98.89
Volume
5.06 million shs
Average Volume
6.23 million shs
Market Capitalization
$110.07 billion
P/E Ratio
29.34
Dividend Yield
3.29%
Price Target
$91.37

Medtronic MarketRank™ Forecast

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
8.0% Upside
$89.53 Price Target
Short Interest
Healthy
0.80% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.04
Upright™ Environmental Score
News Sentiment
0.40mentions of Medtronic in the last 14 days
Based on 36 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.11%
From $5.05 to $5.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Medical Sector

107th out of 1,980 stocks

Electromedical Equipment Industry

1st out of 46 stocks


MDT stock logo

About Medtronic (NYSE:MDT) Stock

Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.

Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.

In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. 

Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. 

Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. 

Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

20 Best Healthcare Dividend Stocks to Invest in (MDT)
Healthcare, like many other sectors, produces dividends. Learn more about how to invest in healthcare trends and earn dividends along the way with MarketBeat.
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs (MDT)
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning
ChatGPT Is Already "Old School"
As good as ChatGPT is at writing content, it still doesn't understand what it's saying. But a new AI technology breakthrough will understand and process information like a human. One young company is leading the way.
A Reversal Is Brewing For Medtronic: Buying The Dip
Medtronic pulled back on soft guidance but this is an opportunity for income investors: medical device makers are rebounding on increased procedures.
Should You Invest in Medtronic plc (MDT)?
Is It Too Late to Buy Medtronic's Stock?
Graphite versus Lithium - What Investors Should Know
Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.
Medtronic (NYSE:MDT) Updates FY 2024 Earnings Guidance
Medtronic (NYSE:MDT) Stock Rating Upgraded by StockNews.com
Why Medtronic Stock Sank Today
Bernstein Reaffirms Their Buy Rating on Medtronic (MDT)
Medtronic (NYSE:MDT) PT Raised to $92.00
BTIG Remains a Hold on Medtronic (MDT)
See More Headlines

MDT Price History

MDT Company Calendar

Ex-Dividend for 4/14 Dividend
3/23/2023
Dividend Payable
4/14/2023
Last Earnings
5/25/2023
Today
6/01/2023
Ex-Dividend for 7/14 Dividend
6/22/2023
Dividend Payable
7/14/2023
Next Earnings (Estimated)
8/22/2023
Fiscal Year End
4/30/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Forecast
$89.53
High Stock Price Forecast
$104.00
Low Stock Price Forecast
$79.00
Forecasted Upside/Downside
+10.4%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
13 Analysts

Profitability

Net Income
$3.76 billion
Pretax Margin
17.18%

Debt

Sales & Book Value

Annual Sales
$31.23 billion
Cash Flow
$7.34 per share
Book Value
$38.83 per share

Miscellaneous

Outstanding Shares
1,330,420,000
Free Float
1,326,566,000
Market Cap
$110.11 billion
Optionable
Optionable
Beta
0.71

Social Links


Key Executives

  • Geoffrey Straub Martha
    Chairman & Chief Executive Officer
  • Megan Fulton Riddle
    Vice President
  • Gregory L. Smith
    Executive VP-Global Operations & Supply Chain
  • Karen L. ParkhillKaren L. Parkhill
    Chief Financial Officer & Executive Vice President
  • Laura Mauri
    CSO, Chief Medical & Regulatory Officer, Senior VP













MDT Stock - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last twelve months. There are currently 2 sell ratings, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price forecast for 2023?

13 brokers have issued 12-month price targets for Medtronic's stock. Their MDT share price forecasts range from $79.00 to $104.00. On average, they expect the company's share price to reach $89.53 in the next year. This suggests a possible upside of 7.8% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2023?

Medtronic's stock was trading at $77.72 on January 1st, 2023. Since then, MDT stock has increased by 6.9% and is now trading at $83.07.
View the best growth stocks for 2023 here
.

Are investors shorting Medtronic?

Medtronic saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 11,410,000 shares, an increase of 39.5% from the April 15th total of 8,180,000 shares. Based on an average daily volume of 5,990,000 shares, the short-interest ratio is currently 1.9 days. Currently, 0.9% of the shares of the stock are short sold.
View Medtronic's Short Interest
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 22nd 2023.
View our MDT earnings forecast
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) issued its quarterly earnings data on Thursday, May, 25th. The medical technology company reported $1.57 earnings per share for the quarter, topping analysts' consensus estimates of $1.56 by $0.01. The medical technology company earned $8.54 billion during the quarter, compared to analyst estimates of $8.25 billion. Medtronic had a trailing twelve-month return on equity of 13.54% and a net margin of 12.03%. The business's quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm posted $1.52 earnings per share.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Wednesday, May 24th. Investors of record on Friday, June 23rd will be paid a dividend of $0.69 per share on Friday, July 14th. This represents a $2.76 annualized dividend and a dividend yield of 3.32%. The ex-dividend date is Thursday, June 22nd. This is a positive change from the stock's previous quarterly dividend of $0.68.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 3.30%. The company has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 96.45%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 49.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2024 earnings guidance on Tuesday, May, 30th. The company provided earnings per share guidance of $5.00-$5.10 for the period, compared to the consensus EPS estimate of $5.20. The company issued revenue guidance of -.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.85%), State Street Corp (4.51%), Wellington Management Group LLP (2.25%), Geode Capital Management LLC (1.97%), JPMorgan Chase & Co. (1.53%) and Bank of New York Mellon Corp (1.51%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $83.07.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $110.52 billion and generates $31.23 billion in revenue each year. The medical technology company earns $3.76 billion in net income (profit) each year or $2.82 on an earnings per share basis.

How many employees does Medtronic have?

The company employs 95,000 workers across the globe.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for the company is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -